Mozifor (Plerixafor) 24mg/1.2ml (20mg/ml)

Mozifor (plerixafor 24mg/1.2ml) is an injectable medication used to help mobilize stem cells in the bloodstream for collection prior to stem cell transplant. This 20mg/ml solution supports patients undergoing certain cancer treatments by enhancing stem cell yield.

Strength

24mg/1.2ml (20mg/ml)

Pack Size

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Mozifor is used to increase the number of stem cells in the bloodstream, making it easier to collect them for stem cell transplants. It is commonly prescribed alongside other medications like filgrastim in patients preparing for autologous stem cell transplantation. People often ask, what is plerixafor used for, and the answer is stem cell mobilization support.

Side Effects

After administration, Mozifor works by blocking a protein that traps stem cells in the bone marrow, allowing them to move into the bloodstream. Patients may notice increased stem cell counts in their blood tests following treatment. The effects are temporary and tied to the treatment schedule.

Precautions & Warnings

Mozifor should be handled with care and administered by a healthcare professional. Patients should inform their provider about any allergies or medical conditions before use. It is important to follow the prescribed injection schedule and attend all follow-up appointments.

Avoid Interactions

Mozifor may interact with other medications that affect the blood or immune system, including certain chemotherapy drugs and growth factors. Patients should discuss all current medications with their doctor to avoid potential interactions. Alcohol and herbal supplements may also influence treatment outcomes.

Frequently Asked Questions

Mozifor is administered as a subcutaneous injection, typically in a clinical setting under medical supervision.

Common side effects may include diarrhea, nausea, and injection site reactions.

Administration is usually performed by a healthcare provider, though some patients may self-inject after proper training.

Patients with severe kidney disease or known allergies to plerixafor should avoid this medication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.